View of ASSESSMENT OF BLEEDING RISK FACTORS DURING WARFARIN THERAPY IN ISCHEMIC HEART DISEASE COMPLICATED BY ATRIAL FIBRILLATION

Return to Issue Details ASSESSMENT OF BLEEDING RISK FACTORS DURING WARFARIN THERAPY IN ISCHEMIC HEART DISEASE COMPLICATED BY ATRIAL FIBRILLATION Download Download PDF